Journal of Health Care Compliance
Looking Ahead: DOJ Enforcement Priorities in 2025
November – December 2024
In 2024, the Department of Justice (DOJ) continued to emerge from a pandemic lull and return to vigorous enforcement of the False Claims Act (FCA) — indeed in February, DOJ announced that it had issued a record 1,504 civil investigative demands in fiscal year 2023, and its current activity levels suggest another record-breaking year. In 2025, the healthcare industry can expect that DOJ will continue to prioritize investigating alleged fraud, waste, and abuse in the industry, with particular attention paid to private equity investment, the Anti-Kickback Statute (AKS), pandemic relief fraud, and cyber fraud.
Contacts
Related Blogs
Capabilities
Suggested News & Insights
First Circuit Clarifies Application of Medicare’s “Reasonable and Necessary” Standard in FCA Cases Against Clinical LabsDecember 8, 2025Sidley Secures Landmark FCA Defense Victory for Novo NordiskNovember 18, 2025U.S. DOJ Announces Renewal of FCA Working GroupNovember - December 2025U.S. Treasury Launches Departmentwide Review of Preference-Based Contracting ProgramsNovember 11, 2025Torrey Cope Featured on Fierce Biotech's The Top Line Podcast Episode, "Unpacking the FDA Transparency Push on CRLs"October 17, 2025DOJ Announces Renewal of FCA Working GroupOctober 2025
- Stay Up To DateSubscribe to Sidley Publications
- Follow Sidley on Social MediaSocial Media Directory
